Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Eberhard L. Renner"'
Autor:
Mayur Brahmania, Eberhard L. Renner, Carla S. Coffin, Eric M. Yoshida, Phil Wong, Marilyn Zeman, Hemant Shah
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 165-171 (2019)
Introduction and aim. The prevalence and incidence of chronic liver disease is increasing resulting, in substantial direct and indirect medical costs. Overuse of investigations, treatments and procedures contribute to rising health care costs and can
Externí odkaz:
https://doaj.org/article/290bb5b677fb4b6693ac2aebef11a2e0
Autor:
Mayur Brahmania, Osman Ahmed, Melissa Kelley, Matthew Kowgier, Korosh Khalili, Rob Beecroft, Eberhard L. Renner, David Wong, Hemant Shah, Jordan Feld, Harry L.A. Janssen, Morris Sherman
Publikováno v:
Annals of Hepatology, Vol 16, Iss 5, Pp 765-771 (2017)
Introduction: Radiofrequency ablation (RFA) is a recommended curative intent treatment option for patients with early stage hepa-tocellular carcinoma (HCC). We investigated if wait times for RFA were associated with residual tumor, tumor recurrence,
Externí odkaz:
https://doaj.org/article/a7c6a07678c441b4a7d2b00617bb9dcd
Autor:
Juan Echeverri, MD, Nicolas Goldaracena, MD, Akhil Kant Singh, MD, Gonzalo Sapisochin, MD, Nazia Selzner, MD, Mark S. Cattral, MD, Paul D. Greig, MD, Les Lilly, MD, Ian D. McGilvray, MD, Gary A. Levy, MD, Anand Ghanekar, MD, Eberhard L. Renner, MD, David R. Grant, MD, Stuart A. McCluskey, MD, Markus Selzner, MD
Publikováno v:
Transplantation Direct, Vol 3, Iss 10, p e213 (2017)
Background. We evaluated patient characteristics of live donor liver transplant (LDLT) recipients undergoing a fast-track protocol without intensive care unit (ICU) admission versus LDLT patients receiving posttransplant ICU care. Methods. Of the 1
Externí odkaz:
https://doaj.org/article/b5f154b7775d4a4a998236f9c1110df6
Autor:
Nabiha Faisal, MD, FCPS, Eric M. Yoshida, Marc Bilodeau, Philip Wong, Mang Ma, Kelly W. Burak, Bandar Al-Judaibi, Eberhard L. Renner, Leslie B. Lilly
Publikováno v:
Annals of Hepatology, Vol 13, Iss 5, Pp 525-532 (2014)
Introduction. Hepatitis C (HCV) continues to be the leading indication for liver transplantation (LT). Sustained virological response (SVR) rates to pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy for recurrent HCV in Genotype 1 (G1) LT re
Externí odkaz:
https://doaj.org/article/844f8a7d86274a84abe445e26c0ea2e5
Autor:
Esther B. Bachli, Jörg Bösiger, Markus Béchir, John F. Stover, Reto Stocker, Marco Maggiorini, Eberhard L. Renner, Beat Müllhaupt, Reto A. Schuepbach
Publikováno v:
Critical Care Research and Practice, Vol 2011 (2011)
Background. The Molecular Adsorbent Recirculating System (MARS) has been shown to clear albumin-bound toxins from patients with liver failure but might cause bleeding complications potentially obscuring survival benefits. We hypothesized that monitor
Externí odkaz:
https://doaj.org/article/b601cc1ca66e4397a3c86ac1e8b2e644
Autor:
Alexandra Shingina, Mamatha Bhat, Jill Tinmouth, Philip Vutien, Joseph Kim, Eberhard L. Renner, Prakesh S. Shah, Elizabeth Uleryk
Publikováno v:
Liver Transplantation. 28:437-453
Living donor liver transplantation (LDLT) emerged in the 1980s as a viable alternative to scarce cadaveric organs for pediatric patients. However, pediatric waitlist mortality remains high. Long-term outcomes of living and deceased donor liver transp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4088c8eaadce3ca159530bb63cfbd3e6
https://doi.org/10.1002/lt.26250
https://doi.org/10.1002/lt.26250
Autor:
Jonathan C. Yeung, Max Marquez, Eberhard L. Renner, Ronald Feld, Geoffrey Liu, Shaf Keshavjee, Joseph Kim, Frances A. Shepherd, Haiyan Jiang, Heather J. Ross, Natasha B. Leighl, Kelvin Young, Penelope A. Bradbury, Tim Aliev
Publikováno v:
Lung Cancer. 147:214-220
Objective Organ transplant recipients (OTR) have an increased risk of developing post-transplant malignancies with lung cancer being one of the most common. In this retrospective study, we investigated incidence, use of systemic therapy and outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0f86f30890a7833b9639e907046af9
https://doi.org/10.1016/j.lungcan.2020.07.020
https://doi.org/10.1016/j.lungcan.2020.07.020
Autor:
Markus Selzner, Aloysious Aravinthan, Waleed Fateen, Leslie B. Lilly, Zita Galvin, Nazia Selzner, Mark S. Cattral, Suresh V Venkatachalapathy, Gonzalo Sapisochin, Adam Doyle, Ian D. McGilvray, Anand Ghanekar, Mamatha Bhat, Eberhard L. Renner, David R. Grant, Assaf Issachar
Publikováno v:
Transplantation. 103:2523-2530
Diabetes mellitus (DM) is said to adversely affect transplant outcomes. The aim of this study was to investigate the impact of pre-existing and new-onset DM on liver transplantation (LT) recipients.A single-center retrospective analysis of prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46da8034522470526e865b9e14e6b49
https://doi.org/10.1097/tp.0000000000002757
https://doi.org/10.1097/tp.0000000000002757
Autor:
Sean P. Cleary, Mark S. Cattral, Eberhard L. Renner, David R. Grant, Anand Ghanekar, Nazia Selzner, Hala Muaddi, Markus Selzner, Oleg Mironov, Wei Zhang, Paul D. Greig, Assaf Issachar, R. Beecroft, Gonzalo Sapisochin, Morris Sherman, Aloysious Aravinthan, John R. Kachura, Leslie B. Lilly, Andre Gorgen, Adam Doyle, Ian D. McGilvray
Publikováno v:
Journal of Hepatology. 70:866-873
Radiofrequency ablation (RFA) is an effective treatment for single hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients will occur outside transplant criteria. We aimed to assess the incidence and risk factors fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8159ffeb97c98557c11468c26da6f6bb
https://doi.org/10.1016/j.jhep.2018.12.027
https://doi.org/10.1016/j.jhep.2018.12.027
Autor:
Eric M. Yoshida, Carla S. Coffin, Marilyn Zeman, Eberhard L. Renner, Mayur Brahmania, Hemant Shah, Phil Wong
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 165-171 (2019)
Introduction and aim. The prevalence and incidence of chronic liver disease is increasing resulting, in substantial direct and indirect medical costs. Overuse of investigations, treatments and procedures contribute to rising health care costs and can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4ac0e23c9a377ebaa1bd63bd63e73de
https://doi.org/10.5604/01.3001.0012.7908
https://doi.org/10.5604/01.3001.0012.7908